Charles A Filion1, Sarah Taylor-Black2, Paul J Maglione3, Lin Radigan3, Charlotte Cunningham-Rundles4. 1. The Division of Clinical Immunology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY; The Division of Clinical Immunology and Allergy, Department of Medicine, Maisonneuve-Rosemont Hospital, University of Montreal, Montreal, Quebec, Canada. 2. The Division of Clinical Immunology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY; The Division of Allergy and Clinical Immunology, Department of Medicine, Darmouth-Hitchcock Concord Medical Center, Concord, NH. 3. The Division of Clinical Immunology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY. 4. The Division of Clinical Immunology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address: charlotte.cunningham-rundles@mssm.edu.
Abstract
BACKGROUND: Common variable immunodeficiency (CVID) and IgG deficiency are 2 of the more prevalent primary humoral immune defects. The former is defined by consensus with criteria for quantitative and qualitative antibody defects, whereas the latter is used to describe patients with reduced IgG, who commonly have recurrent sinopulmonary infections but do not fulfill CVID criteria. However, these patients are often given this diagnosis. OBJECTIVE: To compare immunologic findings and clinical manifestations of 2 large cohorts of patients with CVID or IgG deficiency to better delineate differences between these syndromes. METHODS: We extracted clinical and laboratory data from electronic medical records of patients at our institution who had received International Classification of Disease codes for either CVID, or IgG deficiency. We gathered immunoglobulin levels, lymphocyte subpopulation counts, and serological vaccine responses. In some patients, we performed flow cytometry to determine percentages of memory and switched-memory B cells. We compiled and statistically compared clinical data related to infectious manifestations, bronchiectasis, autoimmune diseases, infiltrative inflammatory processes, and lymphoid malignancies. RESULTS: In contrast to IgG-deficient patients, we found that patients with CVID had lower IgG levels, greater unresponsiveness to most vaccines, lower percentages of memory and isotype switched-memory B cells, and lower CD4 T-cell counts. Clinically, patients with CVID presented similar rates of sinusitis and pneumonias, but a significantly higher prevalence of bronchiectasis and especially noninfectious complications. CONCLUSIONS: CVID and IgG deficiency do not share the same disease spectrum, the former being associated with immunodysregulative manifestations and markers of a more severe immune defect. These data may allow clinicians to distinguish these conditions and the management differences that these patients pose.
BACKGROUND: Common variable immunodeficiency (CVID) and IgG deficiency are 2 of the more prevalent primary humoral immune defects. The former is defined by consensus with criteria for quantitative and qualitative antibody defects, whereas the latter is used to describe patients with reduced IgG, who commonly have recurrent sinopulmonary infections but do not fulfill CVID criteria. However, these patients are often given this diagnosis. OBJECTIVE: To compare immunologic findings and clinical manifestations of 2 large cohorts of patients with CVID or IgG deficiency to better delineate differences between these syndromes. METHODS: We extracted clinical and laboratory data from electronic medical records of patients at our institution who had received International Classification of Disease codes for either CVID, or IgG deficiency. We gathered immunoglobulin levels, lymphocyte subpopulation counts, and serological vaccine responses. In some patients, we performed flow cytometry to determine percentages of memory and switched-memory B cells. We compiled and statistically compared clinical data related to infectious manifestations, bronchiectasis, autoimmune diseases, infiltrative inflammatory processes, and lymphoid malignancies. RESULTS: In contrast to IgG-deficientpatients, we found that patients with CVID had lower IgG levels, greater unresponsiveness to most vaccines, lower percentages of memory and isotype switched-memory B cells, and lower CD4 T-cell counts. Clinically, patients with CVID presented similar rates of sinusitis and pneumonias, but a significantly higher prevalence of bronchiectasis and especially noninfectious complications. CONCLUSIONS:CVID and IgG deficiency do not share the same disease spectrum, the former being associated with immunodysregulative manifestations and markers of a more severe immune defect. These data may allow clinicians to distinguish these conditions and the management differences that these patients pose.
Authors: Cindy S Ma; Stefania Pittaluga; Danielle T Avery; Nathan J Hare; Irina Maric; Amy D Klion; Kim E Nichols; Stuart G Tangye Journal: J Clin Invest Date: 2006-01-19 Impact factor: 14.808
Authors: Jack J Bleesing; Margarida M Souto-Carneiro; William J Savage; Margaret R Brown; Cynthia Martinez; Sule Yavuz; Sebastian Brenner; Richard M Siegel; Mitchell E Horwitz; Peter E Lipsky; Harry L Malech; Thomas A Fleisher Journal: J Immunol Date: 2006-06-01 Impact factor: 5.422
Authors: Klaus Warnatz; Lukas Bossaller; Ulrich Salzer; Andrea Skrabl-Baumgartner; Wolfgang Schwinger; Mirjam van der Burg; Jacques J M van Dongen; Marzena Orlowska-Volk; Rolf Knoth; Anne Durandy; Ruth Draeger; Michael Schlesier; Hans Hartmut Peter; Bodo Grimbacher Journal: Blood Date: 2005-12-29 Impact factor: 22.113
Authors: Claudia Wehr; Teemu Kivioja; Christian Schmitt; Berne Ferry; Torsten Witte; Efrem Eren; Marcela Vlkova; Manuel Hernandez; Drahomira Detkova; Philip R Bos; Gonke Poerksen; Horst von Bernuth; Ulrich Baumann; Sigune Goldacker; Sylvia Gutenberger; Michael Schlesier; Florence Bergeron-van der Cruyssen; Magali Le Garff; Patrice Debré; Roland Jacobs; John Jones; Elizabeth Bateman; Jiri Litzman; P Martin van Hagen; Alessandro Plebani; Reinhold E Schmidt; Vojtech Thon; Isabella Quinti; Teresa Espanol; A David Webster; Helen Chapel; Mauno Vihinen; Eric Oksenhendler; Hans Hartmut Peter; Klaus Warnatz Journal: Blood Date: 2007-09-26 Impact factor: 22.113
Authors: Silvia Sánchez-Ramón; Lin Radigan; Joyce E Yu; Susan Bard; Charlotte Cunningham-Rundles Journal: Clin Immunol Date: 2008-07-11 Impact factor: 3.969
Authors: Helen Chapel; Mary Lucas; Martin Lee; Janne Bjorkander; David Webster; Bodo Grimbacher; Claire Fieschi; Vojtech Thon; Mohammad R Abedi; Lennart Hammarstrom Journal: Blood Date: 2008-03-04 Impact factor: 22.113
Authors: Tyler Harkness; Xiaoqing Fu; Yuqing Zhang; Hyon K Choi; John H Stone; Kimberly G Blumenthal; Zachary S Wallace Journal: Ann Allergy Asthma Immunol Date: 2020-03-27 Impact factor: 6.347
Authors: Luke J Wallace; Matthew S Ware; Charlotte Cunningham-Rundles; Ramsay L Fuleihan; Paul J Maglione Journal: J Allergy Clin Immunol Pract Date: 2021-03-23
Authors: Hans-Hartmut Peter; Hans D Ochs; Charlotte Cunningham-Rundles; Donald C Vinh; Peter Kiessling; Bernhard Greve; Stephen Jolles Journal: J Allergy Clin Immunol Date: 2020-09 Impact factor: 10.793